Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease

Plasma Clusterin Concentrations May Predict Resistance to Intravenous Immunoglobulin in Patients with Kawasaki Disease

Kawasaki disease (KD) is an acute febrile vasculitic syndrome of early childhood often complicated by coronary artery lesion that drastically reduces the quality of life. The study aimed to identify a reliable marker for predicting nonresponsiveness to the first course of intravenous immunoglobulin...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mei-Chen Ou-Yang, Ho-Chang Kuo, I-Chun Lin, Jiunn-Ming Sheen, Fu-Chen Huang, Chih-Cheng Chen, Ying-Hsien Huang, Ying-Jui Lin, Hong-Ren Yu
Format:	Article
Language:	English
Published:	Wiley 2013-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1155/2013/382523
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive modeling of consecutive intravenous immunoglobulin treatment resistance in Kawasaki disease: A nationwide study
by: Eun Jung Cheon, et al.
Published: (2025-01-01)

Crystalline-Like Keratopathy after Intravenous Immunoglobulin Therapy with Incomplete Kawasaki Disease: Case Report and Literature Review
by: Elif Erdem, et al.
Published: (2013-01-01)

Changes in Peripheral Blood Neutrophils, Lymphocytes and IL-10 in Children with Kawasaki Disease from Different Age Groups Undergoing Intravenous Immunoglobulin: A Retrospective Study
by: Chun Zhang, et al.
Published: (2020-01-01)

Plasma exchange alone versus combination with intravenous immunoglobulin/methylprednisolone pulse therapy in severe systemic rheumatic diseases: a retrospective study
by: Jing Guo, et al.
Published: (2024-12-01)

Prophylactic intravenous immunoglobulin use in allogeneic stem cell transplantation; does intravenous immunoglobulin affect survival, sepsis, and engraftment time?
by: Ahmet Kaya, et al.
Published: (2024-12-01)

A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
by: Seiichiro Takeshita, et al.
Published: (2017-01-01)

Argonaute2 and Argonaute4 Involved in the Pathogenesis of Kawasaki Disease via mRNA Expression Profiles
by: Zon-Min Lee, et al.
Published: (2025-01-01)

Cotreatment of Congenital Measles with Vitamin A and Intravenous Immunoglobulin
by: Yasemin Ozsurekci, et al.
Published: (2014-01-01)

Effects of Intravenous Immunoglobulin and Acyclovir in Preventing Neonatal Varicella
by: Waritsara Piyanonpong
Published: (2020-01-01)

CD40 Gene Polymorphisms Associated with Susceptibility and Coronary Artery Lesions of Kawasaki Disease in the Taiwanese Population
by: Ho-Chang Kuo, et al.
Published: (2012-01-01)

Reduced Expression of Antimicrobial Protein Secretory Leukoprotease Inhibitor and Clusterin in Chronic Rhinosinusitis with Nasal Polyps
by: Yanran Huang, et al.
Published: (2021-01-01)

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
by: Brigitta Dombai, et al.
Published: (2017-01-01)

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
by: Lyubomir A. Dourmishev, et al.
Published: (2016-01-01)

Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome
by: Min Cheol Chang, et al.
Published: (2021-01-01)

Severe Periodontal Disease Associated with Long-Term Treatment with Intravenous Immunoglobulin
by: Jôice Dias Corrêa, et al.
Published: (2014-01-01)

Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome
by: Maria Giovanna Danieli, et al.
Published: (2012-01-01)

High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies
by: Yousef Laham, et al.
Published: (2025-01-01)

Intravenous immunoglobulin for mortality and inflammatory status in patients with sepsis: a retrospective database study
by: Hayabusa Takano, et al.
Published: (2025-01-01)

A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins
by: Christian Akem Dimala, et al.
Published: (2021-01-01)

Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
by: Jeet Hemantkumar Patel, et al.
Published: (2020-01-01)

Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
by: Diana Straubel, et al.
Published: (2018-01-01)

Toxic epidermal necrolysis with thrombocytopenia induced by intravenous immunoglobulin: a case report and mini review
by: Yoshihiro Nishita, et al.
Published: (2025-01-01)

Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy
by: Wenhua Xu, et al.
Published: (2020-01-01)

Combination of High-Dose Intravenous Immunoglobulins and Itraconozole in Treating Chronic Mycotic Demyelinating Optic Neuritis
by: Andrew W. Campbell, et al.
Published: (2003-01-01)

The Effect of Prolonged Antenatal Intravenous Immunoglobulin Treatment in Preventing Gestational Alloimmune Liver Disease—A Case Series with Literature Review
by: Eena Sunya Lin, et al.
Published: (2025-01-01)

The secreted host-cell protein clusterin interacts with PmpD and promotes Chlamydia trachomatis infection
by: Fabienne Kocher, et al.
Published: (2025-01-01)

Sweet Syndrome due to Myelodysplastic Syndrome: Possible Therapeutic Role of Intravenous Immunoglobulin in Addition to Standard Treatment
by: Harry H. S. Gill, et al.
Published: (2010-01-01)

Plasma myeloperoxidase interactions with cadmium, lead, arsenic, and selenium and their impact on chronic kidney disease
by: Hsi-Hsien Chen, et al.
Published: (2025-01-01)

Enhancing generalization in a Kawasaki Disease prediction model using data augmentation: Cross-validation of patients from two major hospitals in Taiwan.
by: Chuan-Sheng Hung, et al.
Published: (2024-01-01)

Off-Label Use of Intravenous Immunoglobulin with Methylprednisolone to Treat Parsonage–Turner Syndrome in a United States Marine
by: Carissa M. Sedlacek, et al.
Published: (2021-01-01)

The Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection in Renal Transplant Recipients
by: Gun Hee An, et al.
Published: (2014-01-01)

The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell Transplantation
by: Xiaoping Li, et al.
Published: (2025-01-01)

Clusterin induced by OPC phagocytosis blocks IL-9 secretion to inhibit myelination in a model of Alzheimer's disease
by: Rebecca M. Beiter, et al.
Published: (2025-01-01)

Platelet–Monocyte Aggregate Instigates Inflammation and Vasculopathy in Kawasaki Disease
by: Yuan Zhang, et al.
Published: (2025-02-01)

MicroRNA-155 modulates methotrexate-induced spatial memory impairment by disruption of the blood-brain barrier integrity
by: Yu-Chieh Chen, et al.
Published: (2025-03-01)

Intravenous thrombolysis prevents neurological deterioration in patients with acute pontine infarction
by: Zhenxiao Chai, et al.
Published: (2025-01-01)

Prediction of Immune Infiltration Diagnostic Gene Biomarkers in Kawasaki Disease
by: Hongjun Ba, et al.
Published: (2022-01-01)

Kawasaki Disease: A Clinician’s Update
by: Nathan Jamieson, et al.
Published: (2013-01-01)

Parotitis as an Initial Symptom of Kawasaki Disease
by: Koji Yokoyama
Published: (2017-01-01)

Quantitative N-glycoproteomic analysis reveals glycosylation signatures of plasma immunoglobulin G in systemic sclerosis
by: Lu Cheng, et al.
Published: (2025-02-01)